Wendy Chapman, SVP Clinical Operations at ProNAi Therapeutics Inc (DNAI), sold 3,000 shares at $7.06 ($21K) on 2016-02-22, disclosed to the SEC on 2016-02-24.
Scheduled sale ($21k) by SVP Clinical Operations under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |